Journal of Visceral Surgery最新文献

Intersecting perspectives on the organization and disorganization of our operating theaters.

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-03-27 DOI: 10.1016/j.jviscsurg.2025.03.007

Christelle-Dior Ndjandje, Daniel Eyraud, Sébastien Gaujoux

引用次数: 0

Medical error: From a legal framework to an approach based on surgical risk management. 医疗事故：从法律框架到基于手术风险管理的方法。

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-03-26 DOI: 10.1016/j.jviscsurg.2025.03.002

Margaux Borie, Jean-François Gravié, Frédéric Borie

引用次数: 0

Medical tourism in bariatric surgery: Challenges and perspectives.

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-03-25 DOI: 10.1016/j.jviscsurg.2025.03.005

Fajer Nassour, Jean-Marc Catheline, Régis Cohen

引用次数: 0

Lymphatic mapping using patent blue dye injection for colon cancer.

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-03-18 DOI: 10.1016/j.jviscsurg.2025.03.003

Marc Pocard, Jean-Jacques Tuech

引用次数: 0

Thrombectomy of the inferior vena cava for renal cell carcinoma level 3 thrombus.

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-03-12 DOI: 10.1016/j.jviscsurg.2025.02.007

Louise Barbier, Matthew Haydock, Kamran Zargar, John McCall

引用次数: 0

Rehospitalization after digestive surgery: Which indicators to use?

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-03-10 DOI: 10.1016/j.jviscsurg.2025.02.008

Arnaud Alves, Karem Slim

引用次数: 0

Long stenosis in Crohn's disease: Stricturoplasty according to Finney.

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-03-10 DOI: 10.1016/j.jviscsurg.2025.02.006

Alexandra Pellegrin, Hugo Defives, Charles Sabbagh

引用次数: 0

Voluminous parieto-cutaneous and peritoneal recurrence of colon cancer - Carcinologic resection is always to be considered.

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-02-26 DOI: 10.1016/j.jviscsurg.2025.02.004

Milena Muzzolini, Hélène Hermand, Diane Goere

引用次数: 0

Contraindication to surgery in primary retroperitoneal sarcoma: Retrospective series on 20years of practice in a high-volume sarcoma center.

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-02-24 DOI: 10.1016/j.jviscsurg.2025.01.009

Belkacem Acidi, Matthieu Faron, Olivier Mir, Antonin Levy, Mohammed Ghallab, Ines Kasraoui, Benjamin Verret, Cecile Le Péchoux, Raslislav Bahleda, Andrea Cavalcanti, Axel Le Cesne, Charles Honoré

{"title":"Contraindication to surgery in primary retroperitoneal sarcoma: Retrospective series on 20years of practice in a high-volume sarcoma center.","authors":"Belkacem Acidi, Matthieu Faron, Olivier Mir, Antonin Levy, Mohammed Ghallab, Ines Kasraoui, Benjamin Verret, Cecile Le Péchoux, Raslislav Bahleda, Andrea Cavalcanti, Axel Le Cesne, Charles Honoré","doi":"10.1016/j.jviscsurg.2025.01.009","DOIUrl":"https://doi.org/10.1016/j.jviscsurg.2025.01.009","url":null,"abstract":"Introduction: Surgery is the cornerstone treatment for retroperitoneal sarcomas (RPS). However, contraindications for unresectability are not well-documented in the literature.Aim of the study: This study aims to identify contraindications that prevent surgery for primary RPS in a high-volume sarcoma center.Methods: We retrospectively analyzed all consecutive patients treated for primary RPS at our center from 1995 to 2021.Results: Among the 452 patients treated for primary RPS, 92 (20%) were not offered surgery. The reasons for unresectability were categorized as follows: poor general health or severe comorbidities in 39 patients (42%), preoperative detection of distant metastases in 33 patients (36%), and locally advanced disease in 20 patients (22%). Locally advanced disease included vascular involvement in 14 patients (15%) and vertebral invasion in 6 patients (7%). Among the non-operated patients, 66% received chemotherapy, 16% received radiotherapy, and 5% received combined treatments. The median progression-free survival was 7months, and the median overall survival was 18months. The 1-year overall survival rate was 53%.Conclusion: Contraindications for surgery in patients with primary RPS in a high-volume sarcoma center are not uncommon. The next step should be to differentiate absolute from relative (i.e., preoperative modifiable factors) contraindications.","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143505217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

What is the best management of patients after percutaneous transhepatic gallbladder drainage for acute lithiasic cholecystitis? Comparison of two different strategies.

IF 2 4区医学

Journal of Visceral Surgery Pub Date : 2025-02-24 DOI: 10.1016/j.jviscsurg.2025.01.007

Fanny Sok, François Mauvais, Marion Demouron, Thierry Yzet, Noémie Ammar-Khodja, Jean-Marc Regimbeau

{"title":"What is the best management of patients after percutaneous transhepatic gallbladder drainage for acute lithiasic cholecystitis? Comparison of two different strategies.","authors":"Fanny Sok, François Mauvais, Marion Demouron, Thierry Yzet, Noémie Ammar-Khodja, Jean-Marc Regimbeau","doi":"10.1016/j.jviscsurg.2025.01.007","DOIUrl":"https://doi.org/10.1016/j.jviscsurg.2025.01.007","url":null,"abstract":"Introduction: After percutaneous transhepatic gallbladder drainage (PTGD) in patients with acute lithiasic cholecystitis (ALC), patients are managed on surgical wards. Our aim was to compare two management strategies for these patients.Material: Consecutive patients (2019-2021) who underwent PTGD were included. In Center A (CHOL- DRAIN+ Clamped): clamping of the drain without systematic cholangiography and discharge with the drain clamped, removal of the drain in consultation; Center B (CHOL+ DRAIN-): cholangiography and removal of the drain during hospitalization. The primary endpoint was the success of PTGD (absence of cholecystectomy or death during hospitalization, absence of readmissions for ALC and/or death from biliary causes within 90days). Secondary endpoints were PTGD complications, length of hospitalization, unscheduled cholecystectomy, or biliary-associated readmission within 90days. Analysis was performed in intention-to-treat and per-protocol.Results: Forty patients were included in Center A (CHOL- DRAIN+ Clamped) and 19 in Center B (CHOL+ DRAIN-). They were comparable. In ITT, the PTGD success rate was comparable between groups (85% vs. 63%, P=0.097). Drainage complications (15% vs. 53%, P=0.007) and re-drainage (0% vs. 15.8%, P=0.03), unscheduled cholecystectomy (2% vs. 26%, P=0.037), and readmission for biliary causes (10% vs. 32%, P=0.039) within 90days were less frequent in Center A. Mortality (7.5% vs. 10.5%, P=0.7) and length of stay (12 vs. 13days, P=0.744) were comparable. Cholangiography enabled a change in strategy for 20.3% of cases. PP management was more frequent in Center A (92.5% vs. 52.6%, P=0.004).Conclusion: Drain clamping during hospitalization and removing it during consultation, without systematic cholangiography is a good strategy.","PeriodicalId":49271,"journal":{"name":"Journal of Visceral Surgery","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143505218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0